1. Introduction
Blueberries (
Vaccinium spp.) are widely recognized for their exceptional nutritional and functional value and have recently been classified by the FAO as a ‘superfruit,’ ranking them among the five most health–promoting fruits worldwide. Botanically, blueberries belong to the family
Ericaceae, subfamily
Vaccinoideae, and genus
Vaccinium [
1].
Due to their antioxidant capacity and documented beneficial health effects, blueberries have garnered increasing scientific and commercial interest, particularly in North America and Europe [
2]. As a result, global blueberry production has increased by 526% over the past two decades, reaching 1113 M tons in 2021 [
3].
Blueberries are a natural source of valuable bioactive compounds, including phenolic compounds, sugars, vitamins, minerals, dietary fibre, pectin, and organic acids (e.g., citric acid, ascorbic acid, phenolic acids, and tannins) [
4]. Among these components, phenolic compounds, including stilbenoids, tannins, and flavonoids, such as flavanones, flavanols, quercetin, and anthocyanins, represent 50–80% of the blueberry’s total phenolic content (around 3000 mg/kg), with anthocyanins accounting for up to 60% (16 to 160 mg per 100 g) [
5].
Anthocyanins, primarily cyanidin–derived glycosides, are responsible for the characteristic dark blue pigmentation and are widely considered the primary contributors to the antioxidant, anti–inflammatory, and protective biological effects attributed to blueberry consumption [
6,
7].
Anthocyanins are commonly extracted from blueberries using organic solvents, such as methanol, ethanol, or acetone, often acidified, to facilitate the breakdown of cell structures and enhance pigment solubility. Although effective, these solvents are not classified as GRAS substances, limiting their applicability in food, cosmetic, biomedical, and nutraceutical formulations [
8].
In recent years, in response to increasing regulatory constraints and sustainability considerations, alternative extraction strategies have emerged, including microwave–assisted extraction (MAE) [
9], ultrasound–assisted extraction (UAE) [
10], and protocols using food–grade acids such as citric acid [
10,
11]. Beyond acting as a safe and efficient extraction medium, citric acid also plays an active role in stabilizing anthocyanins through metal chelation. Blueberries naturally contain trace amounts of transition metals such as Fe
2+ and Cu
2+, which can catalyze oxidative reactions (e.g., Fenton–type processes). By binding these ions, citric acid inhibits metal–mediated radical formation, thereby reducing pigment degradation and helping preserve the antioxidant properties of the extract.
Despite their biological value, anthocyanins, as well as polyphenols in general, are chemically unstable and highly sensitive to environmental factors, including temperature, light exposure, pH, oxygen, enzymatic degradation, and the presence of metal ions [
12]. This limited stability significantly affects bioavailability and restricts the direct incorporation of the compound into formulations intended for controlled release or long–term storage.
To address these limitations, encapsulation strategies such as micelles, dendrimers, complex condensates, cyclodextrins, solid lipid nanoparticles, cellulose nanocrystals, polyelectrolyte complexes, nanoliposomes, and various polymer–based delivery systems have been investigated [
2,
13]. However, many of these systems still present drawbacks related to regulatory approval, production costs, scalability, or safety. Among biocompatible polymers already approved for food and biomedical applications, gellan gum (GG) emerges as a promising candidate. GG is a microbial polysaccharide produced by species of
Sphingomonas, such as
S. pseudosanguinis and
S. yabuuchiae [
14], and is composed of repeating tetrasaccharide units [
15].
GG is widely used in the food industry, for example, in the production of juices, confectionery, powdered beverages, jellies, jams, margarine, and yoghurt [
16], and was authorized by the European Union’s Scientific Committee for Food in 1990 for use at concentrations ranging from 0.1 to 1.0%, under the code E418 [
17]. One of the key advantages of GG is its ability to form hydrogel beads in the presence of divalent or trivalent cations. This property enables pH–responsive behaviour: under acidic conditions (e.g., stomach pH), protonation of carboxylic groups limits swelling and release, whereas at higher pH (e.g., intestinal conditions), deprotonation increases swelling and facilitates controlled release [
18].
Unlike cyclodextrin inclusion complexes, which are mainly suitable for low–molecular–weight compounds and often exhibit limited loading capacity, and liposomal systems, which are prone to aggregation and structural instability during storage and under gastrointestinal conditions, gellan gum hydrogels can accommodate complex multicomponent systems, such as plant extracts, within their porous three–dimensional network [
14,
19]. Taken together, these characteristics make gellan gum microspheres particularly attractive for the development of cost–effective, scalable, and stimuli–responsive delivery systems for natural antioxidants [
20,
21].
This study focuses on the development and characterization of gellan gum–based microspheres for the incorporation of blueberry extract (BEX), to obtain a dry, rehydratable delivery system suitable for use at the time of application.
2. Materials and Methods
2.1. Materials
Pure blueberry juice was purchased from Baule Volante Srl (Castel Maggiore, BO, Italy). Bidistilled water was obtained from Millipore (Molsheim, France). Citric acid, methanol, ethanol, acetylsalicylic acid, and potassium acetate were purchased from Carlo Erba (Milan, Italy). Isopropanol, DPPH (2,2–diphenyl–1–picrylhydrazyl), quercetin, and dichloromethane were supplied by Sigma–Aldrich (Saint–Quentin–Fallavier, France). The Folin–Ciocalteu reagent was obtained from Sigma–Aldrich (Buchs, Switzerland), while phosphatidylcholine and cyanidin chloride were purchased from Sigma–Aldrich (Shangai, China and St. Louis, MO, USA, respectively). Sodium carbonate and sodium hydroxide were purchased from Baker Analyzed Reagents (Deventer, The Netherlands). Aluminum chloride (reagent grade certified) was obtained from Chimica Strola (Turin, Italy). Gellan gum (GG) was purchased from Fluka (St. Louis, MO, USA).
2.2. Preparation of Blueberry Extract (BEX)
The preparation of blueberry extract (BEX) from blueberry juice was carried out using a mild aqueous medium consisting of a 4% (w/v) citric acid solution, aimed at preserving and stabilizing the antioxidant activity of the final dried extract. In particular, this procedure was optimized to enhance the stability and preserve the bioactivity of functional compounds such as anthocyanins. Citric acid was selected not only as a mild and food–grade acidifying agent but also as a natural chelating and stabilizing compound, limiting metal–mediated oxidative degradation. The use of low–temperature treatment conditions further contributed to preserving the native structure of anthocyanins and maintaining antioxidant integrity. To prepare BEX, pure blueberry juice was first filtered using a Büchner funnel fitted with a 0.8 µm nylon membrane filter (Whatman Schleicher & Schuell, Dassel, Germany) connected to a water vacuum pump, in order to remove coarse particulates and pulp residues. The clarified liquid fraction was then diluted 1:1 (v/v) with a 4% (w/v) citric acid solution. The resulting filtrate was subsequently freeze–dried (T = −40 °C) for 48 h using a freeze–dryer (Christ Alpha 1–4). The yield of solid residue was determined to be approximately 40 mg/mL of filtrate. The lyophilized material was sealed and stored at −20 °C until further use.
2.3. Characterization of Blueberry Extract (BEX)
The compositional analysis of BEX was carried out by determining total polyphenols (PHCs), total flavonoids, and anthocyanins by UV–Vis spectroscopy.
The total polyphenol content (PHCs) was measured using the Folin–Ciocalteu method. The lyophilized filtrate was rehydrated with a 4% (
w/
v) citric acid solution to obtain a final concentration of 40 mg/mL. An aliquot of 0.5 mL of this solution was mixed with 1.5 mL of methanol and 2.5 mL of Folin–Ciocalteu reagent (diluted 1:10 with bidistilled water). After 5 min, 2.5 mL of a 7.5% sodium carbonate solution was added. The test tubes were then incubated at room temperature for 2 h. Absorbance was measured at 765 nm by UV–Vis spectroscopy. As a blank, a solution containing 0.5 mL of 4% (
w/
v) citric acid solution, 1.5 mL of methanol, 2.5 mL of Folin–Ciocalteu reagent, and 2.5 mL of 7.5% sodium carbonate solution was used. Quercetin served as the reference standard, and the calibration curve (
Figure S1) was prepared with concentrations of 50.0, 25, and 12.5, 6.25 and 3.125 µg/mL [
22].
The total flavonoid content (FLA) was determined using an AlCl
3–based colorimetric method by UV–Vis spectroscopy [
19,
20,
21,
22,
23]. The same rehydrated lyophilized extract solution (40 mg/mL) described above was used. An aliquot of 0.5 mL of this solution was mixed with 1.5 mL of methanol, 0.1 mL of 10% AlCl
3 solution, 0.1 mL of 1 M potassium acetate solution, and 2.8 mL of bidistilled water. After incubation at room temperature for 30 min, the absorbance was measured at a wavelength of 415 nm. The blank solution was prepared following the same procedure, replacing the 0.1 mL of AlCl
3 solution with the same volume of bidistilled water. The total flavonoid content was calculated using quercetin as the reference standard. The calibration curve (
Figure S2) was prepared using quercetin standard solutions at concentrations of 50, 25, 12.5, and 6.25 and 3.125 µg/mL [
24].
Anthocyanin content of the lyophilized blueberry extract was determined by UV–Vis spectrophotometric analysis at 515 nm using cyanidin as a reference standard. A citric acid solution (2.5 mg/mL) was prepared, and its pH was adjusted to 5.5 by dropwise addition of 0.01 M NaOH using a calibrated pH metre (pH–Meter Basic 20+, Crison). The pH value (5.5) was chosen to mimic the physiological pH of the skin, in view of potential cosmetic and dermatological applications. A quantity of 10 mg of lyophilized extract was dissolved in 5 mL of the citric acid solution (pH 5.5), yielding a final extract concentration of 2.0 mg/mL. Absorbance was measured at 515 nm. As blank, citric acid solution at the respective pH value was used. The calibration curve (
Figure S3) was prepared by dissolving 1 mg of cyanidin in 500 µL of ethanol. From this stock solution, 100 µL were diluted to 5 mL with citric acid solution (pH = 5.5), yielding a cyanidin concentration of 40 µg/mL [
25]. This solution was further diluted to obtain cyanidin concentrations of 40, 30, 20, 10, and 5 µg/mL for the calibration curve (
Figure S3). The antioxidant activity of the freshly prepared extract was assessed by DPPH assay as described in
Section 2.6.5. All UV–Vis analyses were carried out at room temperature using a Shimadzu UV–2100 UV–Vis spectrophotometer (Shimadzu Corporation, Kyoto, Japan) at room temperature.
2.4. Microsphere Preparation
For the preparation of the microspheres (G–MPs), the dispersed phase of the emulsion was first prepared by formulating a 1.5% (w/v) aqueous dispersion of GG. This was obtained by adding 0.3 g of gellan powder to 20 mL of bidistilled water under continuous stirring at 70 °C until a homogeneous dispersion was achieved. Subsequently, the continuous (dispersant) phase was prepared by dissolving phosphatidylcholine in dichloromethane to obtain a 1% (w/v) solution. Specifically, 2.0 g of phosphatidylcholine was solubilized in 200 mL of dichloromethane under continuous stirring at room temperature for 30 min, until the phospholipid was completely dissolved. The process was carried out at ambient temperature to prevent the rapid evaporation of dichloromethane. The emulsion system required for G–MPs formation was then assembled using a three–neck round–bottom flask with a bubble condenser (Sigma Aldrich, St. Louis, MO, USA). A mechanical stirrer (Heidolph RZR 2020, 50 W, Heidolph Instruments GmbH, Schwabach, Germany) equipped with a speed controller (operating range: 40–2000 rpm) was used to ensure controlled agitation throughout the microsphere fabrication process. 200 mL of the phosphatidylcholine (PC) solution in dichloromethane was introduced into a round–bottom flask. Once the temperature reached 50 °C, mild stirring was applied at 300 rpm. Subsequently, 20 mL of the gellan aqueous solution, preheated to 50 °C, was added slowly to the flask. After the complete addition of the dispersed phase, the stirring speed was increased to 800 rpm, and the emulsion was maintained under these conditions for 30 min to allow proper microsphere formation. At the end of the first stage, the heating source was stopped, and the system was maintained under constant stirring at 800 rpm for an additional 2 h. A bubble condenser was kept in place throughout the whole process to prevent evaporation of the solution within the flask. The three–neck round–bottom flask containing the emulsion was then immersed in an ice bath, and the stirring speed was adjusted to 400 rpm for 30 min. This cooling step was performed to lower the system temperature and promote the final formation of G–MPs. The reduction in temperature inhibits particle coalescence and favours gelation of the gellan, leading to the stabilization of the microspheres. The emulsion was stored for 12 h at 4 °C. After this resting period, the contents of the flask were transferred to a separatory funnel and subjected to several washing steps using pure isopropanol. These washes were carried out to remove residual phosphatidylcholine adsorbed onto the surface of the microspheres during the production process. Subsequently, the microspheres were dried overnight in an oven at 30 °C. After the drying process, the microspheres were weighed to determine the production yield, which was calculated to be 93.5% (calculated with respect to the starting GG amount).
2.5. Loading of Microspheres with BEX
BEX was loaded into the G–MPs via absorption (
Figure 1), a method preferred over incorporation during the microsphere formation phase, since the solvents used in the microsphere post–formation washing steps could extract part of the incorporated extract, leading to losses and reduced reproducibility. Specifically, 200 mg of lyophilized extract was dissolved in 2 mL of an aqueous citric acid solution (4%
w/
v, pH 2.5) and subsequently placed in direct contact with 200 mg of G–MPs, and kept in direct contact for 1 h at room temperature, until complete absorption of the liquid phase was observed. After the absorption process, the microspheres (G–MPs–BEX) were dried overnight in an oven at 30 °C. The loading capacity was calculated for each main bioactive fraction by relating the amount of bioactive compounds contained in BEX used for loading to the total mass of the microspheres (200 mg). Based on the compositional analysis of BEX, the loading capacity of G–MPs was 1.38% for total polyphenols, 0.165% for flavonoids, and 0.243% for anthocyanins.
2.6. Loaded Microspheres Characterization
2.6.1. Morphological Characterization
The microspheres, both unloaded and loaded with BEX (G–MPs and G–MPs–BEX), were analyzed using scanning electron microscopy (SEM, JEOL JSM 5600, JEOL Ltd., Tokyo, Japan), after being gold–coated by sputtering, and were also observed under optical microscopy (OM), Leica S9i, (Wetzlar, Germany) at 300× magnification.
2.6.2. Swelling Degree
The OM images were used to determine the average diameter of the microspheres, both G–MPs and G–MPs–BEX, in the dry state and after subsequent hydration with distilled water. Measurements were performed on representative samples comprising at least 35 microspheres. Only isolated microspheres were considered for diameter measurements, while aggregated or overlapping microspheres were excluded from the analysis. The swelling degree was also assessed for G–MPs–BEX after a few minutes and after two days of immersion in an aqueous medium. The degree of swelling (
Sw) was calculated using the equation below (Equation (1)) to quantify the water absorption capacity of the matrix.
where %
indicates the percentage swelling,
is the average diameter of the swollen microspheres, and
is the average diameter of the dry microspheres.
2.6.3. FTIR–ATR and Imaging Analysis
The G–MPs were further characterized by Fourier–Transform Infrared (FTIR) spectroscopy using the Spectrum Spotlight system (PerkinElmer) in ATR mode, within the wavenumber range of 4000–500 cm−1, at a spectral resolution of 4 cm−1 and by using 36 scans per spectrum. FTIR chemical imaging analyses were performed using a PerkinElmer Spectrum One FT–IR spectrometer (Waltham, MA, USA) equipped with a Universal ATR sampling accessory and a Spectrum Spotlight 300 FT–IR imaging system operated in ‘image’ mode (PerkinElmer Spotlight 300, Shelton, CT, USA). Spectral images were acquired in micro–ATR mode over a 1 mm × 1 mm area at a spatial resolution of 25 μm per pixel, using a liquid nitrogen–cooled 16–pixel mercury cadmium telluride (MCT–A) line detector (InfraTec, Dresden, Germany). Each absorbance spectrum composing the IR images was the result of 16 scans and was recorded for each pixel in the wavenumber range of 4000–752 cm−1, with a spectral resolution of 4 cm−1. Background scans were collected from a region free of the sample. Specific areas of interest were first identified using an optical microscope, and the ATR objective was brought into contact with the sample surface. Spectra generated from the surface layers were collected, and IR spectral images were produced. The obtained spectra were pre–processed using Spotlight software, applying a 9–point Savitzky–Golay smoothing filter (PerkinElmer, MA, USA). Full spectral maps were then analyzed to generate chemical maps, correlation maps, and band absorbance ratios, allowing assessment of the chemical homogeneity of the sample. The chemical map provided an average spectrum representative of the sample, which served as a reference spectrum. Spectra within the spectral images were compared to this reference spectrum to produce correlation maps, highlighting areas of the sample with the highest spectral similarity. Finally, Principal Component Analysis (PCA) was employed as a statistical tool to evaluate variations across the spectral data, enabling the identification and differentiation of distinct spectral groups. All stages of generation, pre–processing, and interpretation of chemical and correlation maps were carried out using Spotlight software 1.3.
2.6.4. Release Kinetics of Polyphenols
The release kinetics of the extract loaded into the microspheres were investigated through two complementary studies.
1st study
In the first study, the overall release of polyphenolic compounds was evaluated under different pH conditions (pH 2.5, 5.5, and 9) in order to assess the pH–dependent behaviour of the system, simulating acidic environments, physiological skin pH, and basic conditions typical of cutaneous infections. For each pH condition, six independent tubes (sacrificial samples) were prepared, each tube containing 10 mg of G–MPs–BEX, dispersed in 5 mL of citric acid solution (2.5 mg/mL) at pH 2.5 or 5.5, or in a NaOH solution adjusted to pH 9 (starting from a 0.01 M NaOH solution). The release study was carried out over a time interval ranging from 0 to 360 min, with samples collected at 0, 5, 30, 60, 120, and 360 min. Each tube was assigned to a single sampling time point. In each tube, 10 mg of loaded microspheres were immersed in the corresponding release medium and kept in contact without agitation. At each sampling time, a 0.5 mL aliquot of the release medium was withdrawn and analyzed after incubation at room temperature for 2 h, as described in
Section 2.3. The amount of released polyphenols was quantified using the Folin–Ciocalteu method at 765 nm, as described in
Section 2.3. The blank consisted of 0.5 mL of the corresponding release medium (citric acid solution at pH 2.5 or 5.5, or NaOH solution at pH 9) without microspheres, 1.5 mL of methanol, 2.5 mL of Folin–Ciocalteu reagent (diluted 1:10 with bidistilled water), and 2.5 mL of a 7.5% sodium carbonate solution.
2nd study
In the second release study, flavonoids were further investigated at pH 5.5, (simulating the physiological environments of the skin). G–MPs–BEX (10 mg) were dispersed in 2.5 mL of citric acid solution at pH 5.5, and six independent tubes (sacrificial samples) were prepared. Samples were collected at 0, 15, and 30 min, and 1, 2, and 4 h. The amount of released flavonoids was quantified using the AlCl
3–based colorimetric method by UV–Vis spectroscopy at 415 nm, following the procedure described in
Section 2.3. The blank was prepared following the same procedure, replacing the AlCl
3 solution with the same volume of bidistilled water.
In the same experimental set–up, anthocyanin release kinetics were evaluated at pH 5.5, using the same conditions and sampling time points (0, 15, and 30 min, 1, 2, and 4 h). Anthocyanins were quantified by direct UV–Vis spectrophotometric analysis at 515 nm, following the procedure described in
Section 2.3. The analysis was performed directly on the release medium without additional reagents, using citric acid solution at pH 5.5 without microspheres as blank.
2.6.5. Evaluation of Antioxidant Activity
Antioxidant activity was evaluated using the DPPH assay. A total of 2 mg of lyophilized extract was dissolved in 20 mL of citric acid solution (2.5 mg/mL and pH = 5.5), obtaining a stock solution of 100 µg/mL, which was further diluted with the same citric acid solution (pH 5.5) to concentrations of 50.0, 25.0, 12.5, 6.25, and 3.125 µg/mL. The 0.004% (
w/
v) DPPH solution was prepared by dissolving 4 mg of DPPH in 100 mL of ethanol. To 1 mL of each dilution, 3 mL of the DPPH solution was added, and the tubes were incubated in the dark at room temperature for 30 min. Absorbance was measured at 517 nm using a water/ethanol solution (1:3) acidified by adding an appropriate volume of citric acid solution (2.5 mg/mL) to reach pH 5.5 used as a blank. Antioxidant activity was calculated using the following Equation (2).
where
is the absorbance of the DPPH solution prepared as described above and containing no extract, and
is the absorbance of the sample containing the extract [
26]. Acetylsalicylic acid was used as a positive control to verify the responsiveness and consistency of the DPPH assay under the applied experimental conditions. The test was conducted on freshly lyophilized blueberry extract, and after 23 and 60 days of storage at −18 °C in sealed containers. Antioxidant activity was determined at pH 5.5. Finally, the antioxidant activity was assessed on the release samples obtained from microspheres after 5 and 120 min, using both freshly prepared and 23–day stored microspheres. In this study, the DPPH assay was applied to monitor variations in the antioxidant activity of BEX under different conditions, including fresh extract, storage, encapsulation into gellan gum microspheres, and release, enabling a direct comparison within the same experimental framework.
All experiments were performed at least in triplicate, and the results are expressed as mean ± standard deviation (SD). Statistical analysis and graphical representations were carried out using Origin(Pro)® software (version 2018, OriginLab Corporation, Northampton, MA, USA). The statistical significance of the differences in antioxidant activity among different experimental conditions (storage times, concentration and release conditions) was evaluated using one–way analysis of variance (ANOVA, Origin(Pro)® software version 2018, OriginLab Corporation, Northampton, MA, USA). When significant differences were detected, Tukey’s post–test was applied. A p–value < 0.05 was considered statistically significant.
2.6.6. Rheological Analysis
The rheological behaviour of an aqueous dispersion of microspheres, both G–MPs and G–MPs–BEX, was investigated using a rotational rheometer (Kinexus, Malvern Panalytical, Malvern, UK) with acone geometry used for viscometric test. Measurements were performed at room temperature on bubble–free samples. Flow curves were recorded over a shear rate range from 0.1 s−1 to 500 s−1. The aqueous dispersion was prepared by dispersing 10 mg of microspheres in 100 µL of an aqueous citric acid solution at pH 5.5.
4. Conclusions
The aim of this work was the development and characterization of a formulation based on gellan gum microspheres loaded with blueberry extract (BEX), designed to be stored in a dry state and hydrated at the time of use. The selected polymeric matrix, gellan gum, is a biocompatible and safe polysaccharide, widely used in the food sector. Owing to its high water absorption capacity, it enables the formation of a highly hydrated gel. The blueberry extract, known for its antioxidant and anti–inflammatory properties, was selected as the active ingredient due to its high content of polyphenols and anthocyanins. An important feature of this work is the use of a mild citric acid–based extraction method, replacing conventional organic solvent approaches. This strategy was selected to better preserve the integrity of the bioactive compounds and ensure compatibility with cosmetic, nutraceutical, and biomedical applications. Analyses performed on the extract confirmed a good concentration of polyphenolic compounds, thus demonstrating the effectiveness of the extraction method used. The gellan gum microspheres obtained were morphologically suitable for release applications, presenting a spherical shape and porous surface features that are favourable for the absorption and diffusion of active compounds. Swelling tests showed that the hydration capacity of the microspheres was not compromised by the loading with the extract, indicating that the moisturizing properties of the polysaccharide matrix remained unchanged. FT–IR analyses performed on the G–MPs–BEX confirmed the successful absorption of the extract, revealing hydrogen bonding interactions between the matrix and the active compounds. These interactions did not hinder the release, which proved to be rapid for both classes of compounds detected (polyphenols and anthocyanins), reaching maximum release levels within 30 min. The dry storage procedure for the extract was effective in preserving its antioxidant properties for at least 60 days. Moreover, even after loading into the microspheres and under simulated storage conditions (sealed container at room temperature), the antioxidant activity remained stable for at least 23 days. From a rheological point of view, both the gellan gum gel and the BEX–containing formulation exhibited pseudoplastic behaviour, characterized by a decrease in viscosity with increasing shear rate. The addition of the extract resulted in an overall increase in gel viscosity, suggesting a possible structural interaction between the matrix and the active ingredient. The study of the release kinetics of the extract from the microspheres showed a trend similar to that of the anthocyanins and polyphenols, confirming that the therapeutic components are released efficiently. Although further studies, including cytotoxicity testing, more comprehensive rheological characterization, skin permeation studies, and microbiological stability evaluations are required to confirm safety, efficacy, and suitability for practical applications, the results demonstrate the feasibility of using gellan gum microspheres as carriers for blueberry extract, and more generally for natural bioactive compounds, in the development of cosmetic and biomedical products or delivery systems.